Charbel Moussa

15.6k total citations · 1 hit paper
83 papers, 4.2k citations indexed

About

Charbel Moussa is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Charbel Moussa has authored 83 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Neurology, 32 papers in Cellular and Molecular Neuroscience and 30 papers in Physiology. Recurrent topics in Charbel Moussa's work include Parkinson's Disease Mechanisms and Treatments (31 papers), Alzheimer's disease research and treatments (29 papers) and Autophagy in Disease and Therapy (19 papers). Charbel Moussa is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (31 papers), Alzheimer's disease research and treatments (29 papers) and Autophagy in Disease and Therapy (19 papers). Charbel Moussa collaborates with scholars based in United States, China and Australia. Charbel Moussa's co-authors include Michaeline Hebron, Irina Lonskaya, Raymond Scott Turner, Jaeil Ahn, Xu Huang, Preeti J. Khandelwal, Alexander M. Herman, Robert A. Rissman, Paul Aisen and G. William Rebeck and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Charbel Moussa

82 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease

2017 568 citations Charbel Moussa, Michaeline Hebron et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charbel Moussa United States	36	1.6k	1.5k	1.5k	1.0k	793	83	4.2k
Michaeline Hebron United States	25	837 0.5×	886 0.6×	847 0.6×	549 0.5×	490 0.6×	47	2.5k
Yunjong Lee South Korea	27	802 0.5×	1.4k 0.9×	1.8k 1.2×	894 0.9×	686 0.9×	69	3.6k
Bobby Thomas United States	39	1.5k 1.0×	2.9k 1.9×	2.9k 2.0×	1.7k 1.7×	704 0.9×	71	6.3k
Eunsung Junn United States	33	1.0k 0.7×	2.3k 1.6×	3.0k 2.0×	1.6k 1.6×	483 0.6×	44	5.8k
Yungui Zhou United States	22	2.2k 1.4×	404 0.3×	1.5k 1.0×	706 0.7×	483 0.6×	29	4.3k
Gundars Goldsteins Finland	34	1.3k 0.8×	914 0.6×	1.5k 1.1×	1.1k 1.1×	309 0.4×	50	4.6k
Jordi Magrané United States	27	1.0k 0.7×	1.4k 1.0×	2.2k 1.5×	781 0.8×	1.1k 1.4×	36	3.9k
Shaida A. Andrabi United States	28	792 0.5×	1.4k 0.9×	3.1k 2.1×	802 0.8×	804 1.0×	45	5.5k
Jan Lewerenz Germany	29	580 0.4×	974 0.7×	1.9k 1.3×	950 0.9×	416 0.5×	79	4.5k
Wenzhang Wang China	26	1.5k 0.9×	901 0.6×	2.2k 1.5×	502 0.5×	461 0.6×	49	4.1k

Countries citing papers authored by Charbel Moussa

Since Specialization

Citations

This map shows the geographic impact of Charbel Moussa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charbel Moussa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charbel Moussa more than expected).

Fields of papers citing papers by Charbel Moussa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charbel Moussa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charbel Moussa. The network helps show where Charbel Moussa may publish in the future.

Co-authorship network of co-authors of Charbel Moussa

This figure shows the co-authorship network connecting the top 25 collaborators of Charbel Moussa. A scholar is included among the top collaborators of Charbel Moussa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charbel Moussa. Charbel Moussa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Algarzae, Norah K., et al.. (2024). Tyrosine kinases: multifaceted receptors at the intersection of several neurodegenerative disease-associated processes. SHILAP Revista de lepidopterología. 3. 1458038–1458038. 1 indexed citations

Hebron, Michaeline, et al.. (2024). c-KIT inhibitors reduce pathology and improve behavior in the Tg(SwDI) model of Alzheimer’s disease. Life Science Alliance. 7(10). e202402625–e202402625. 4 indexed citations

Liu, Xiaoguang, Kaluvu Balaraman, Ciarán C. Lynch, et al.. (2022). Inhibition of Ubiquitin-Specific Protease-13 Improves Behavioral Performance in Alpha-Synuclein Expressing Mice. International Journal of Molecular Sciences. 23(15). 8131–8131. 8 indexed citations

Liu, Xiaoguang, Kaluvu Balaraman, Ciarán C. Lynch, et al.. (2021). Novel Ubiquitin Specific Protease-13 Inhibitors Alleviate Neurodegenerative Pathology. Metabolites. 11(9). 622–622. 18 indexed citations

Pagán, Fernando, Yasar Torres‐Yaghi, Michaeline Hebron, Jaeil Ahn, & Charbel Moussa. (2021). Long-term Safety and Clinical Effects of Nilotinib in Parkinson’s Disease (4799). Neurology. 96(15_supplement). 1 indexed citations

Fowler, Alan J., Michaeline Hebron, Yasar Torres‐Yaghi, et al.. (2020). A novel small molecule tyrosine kinase inhibitor (GUtinib) preferentially targets discoidin domain receptors and reduces toxic proteins in neurodegeneration (5398). Neurology. 94(15_supplement). 1 indexed citations

Hebron, Michaeline, et al.. (2018). Tau clearance improves astrocytic function and brain glutamate-glutamine cycle. Journal of the Neurological Sciences. 391. 90–99. 38 indexed citations

Olszewski, Rafal T., Karolina J. Janczura, Tomasz Bzdega, et al.. (2017). NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer’s, and Ethanol Intoxication. Neurochemical Research. 42(9). 2646–2657. 24 indexed citations

Pagán, Fernando, Yasar Torres‐Yaghi, Michaeline Hebron, et al.. (2016). Nilotinib Improves Motor Skills, Cognition and Autonomic Function in Open-Label Phase I Clinical Trial in Parkinsons Disease with Dementia and Lewy Body Dementia (I1.008). Neurology. 86(16_supplement). 1 indexed citations

10.

Hebron, Michaeline, Jacqueline Smith, Charisse N. Winston, et al.. (2016). Tyrosine kinase inhibition reverses TDP‐43 effects on synaptic protein expression, astrocytic function and amino acid dis‐homeostasis. Journal of Neurochemistry. 139(4). 610–623. 35 indexed citations

11.

Moussa, Charbel. (2015). Parkin Is Dispensable for Mitochondrial Function, but Its Ubiquitin Ligase Activity Is Critical for Macroautophagy and Neurotransmitters: Therapeutic Potential beyond Parkinson's Disease. Neurodegenerative Diseases. 15(5). 259–270. 10 indexed citations

12.

Chen, Wenqiang, Irina Lonskaya, Michaeline Hebron, et al.. (2014). Parkin-mediated reduction of nuclear and soluble TDP-43 reverses behavioral decline in symptomatic mice. Human Molecular Genetics. 23(18). 4960–4969. 33 indexed citations

13.

Zhao, Wenchang, Sonya B. Dumanis, Irfan Y. Tamboli, et al.. (2013). Human APOE genotype affects intraneuronal A 1-42 accumulation in a lentiviral gene transfer model. Human Molecular Genetics. 23(5). 1365–1375. 27 indexed citations

14.

Lonskaya, Irina, et al.. (2012). Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson’s disease. Neuroscience. 232. 90–105. 56 indexed citations

15.

Herman, Alexander M., Preeti J. Khandelwal, G. William Rebeck, & Charbel Moussa. (2012). Wild type TDP-43 induces neuro-inflammation and alters APP metabolism in lentiviral gene transfer models. Experimental Neurology. 235(1). 297–305. 37 indexed citations

16.

Lee, Kyung‐Jin, Charbel Moussa, Young Ju Lee, et al.. (2010). Beta amyloid-independent role of amyloid precursor protein in generation and maintenance of dendritic spines. Neuroscience. 169(1). 344–356. 101 indexed citations

17.

Khandelwal, Preeti J., Sonya B. Dumanis, Li Feng, et al.. (2010). Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model. Molecular Neurodegeneration. 5(1). 47–47. 65 indexed citations

18.

Rebeck, G. William, Hyang‐Sook Hoe, & Charbel Moussa. (2010). β-Amyloid1–42 Gene Transfer Model Exhibits Intraneuronal Amyloid, Gliosis, Tau Phosphorylation, and Neuronal Loss. Journal of Biological Chemistry. 285(10). 7440–7446. 48 indexed citations

19.

Moussa, Charbel, Qinghao Fu, Pravir Kumar, et al.. (2006). Transgenic expression of B‐APP in fast‐twitch skeletal muscle leads to calcium dyshomeostasis and IBM‐like pathology. The FASEB Journal. 20(12). 2165–2167. 32 indexed citations

20.

Moussa, Charbel, Christophe Wersinger, Milan Rusnak, York Tomita, & Anita Sidhu. (2004). Abnormal migration of human wild-type α-synuclein upon gel electrophoresis. Neuroscience Letters. 371(2-3). 239–243. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact